Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.44 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22418053 | 0.93 | TSHR (0.68) | TSHRSLC6A5HPGDMEN1KMT2A | |
| SCHEMBL21155013 | 0.91 | TSHR (0.70) | TSHRSLC6A5HPGDMEN1KMT2A | |
| SCHEMBL26742630 | 0.91 | TSHR (0.59) | TSHRSLC6A5HPGDMEN1KMT2A | |
| SCHEMBL8574782 | 0.91 | TSHR (0.88) | TSHRHPGDMEN1KMT2AKDM4E | |
| SCHEMBL4270085 | 0.91 | TSHR (0.88) | TSHRHPGDMEN1KMT2AKDM4E | |
| SCHEMBL12013650 | 0.91 | TSHR (0.88) | TSHRHPGDMEN1KMT2AKDM4E | |
| SCHEMBL12013653 | 0.91 | TSHR (0.88) | TSHRHPGDMEN1KMT2AKDM4E | |
| SCHEMBL26349750 | 0.91 | TSHR (0.60) | TSHRSLC6A5HPGDMEN1KMT2A | |
| SCHEMBL13431136 | 0.88 | TSHR (0.76) | TSHRHPGDMEN1KMT2AKDM4E | |
| SCHEMBL16190625 | 0.88 | TSHR (0.65) | TSHRSLC6A5HPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3243504-A1 | IMPROVED LIPID FORMULATION | Arbutus Biopharma Corporation (CA) | 2017-11-15 | — | — | EP | disclosed |
| US-9114177-B2 | Block copolymer having phenylboronic acid group introduced therein, and use thereof | THE UNIVERSITY OF TOKYO (JP) | 2015-08-25 | — | — | US | disclosed |
| US-20150051347-A1 | BLOCK COPOLYMER HAVING PHENYLBORONIC ACID GROUP INTRODUCED THEREIN, AND USE THEREOF | THE UNIVERSITY OF TOKYO (JP) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051347-A1 | BLOCK COPOLYMER HAVING PHENYLBORONIC ACID GROUP INTRODUCED THEREIN, AND USE THEREOF | SLC1A5, BPGM, BDKRB1 | TSHR 1108/4885SLC6A5 810/4885HPGD 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.